Spacer Effects on in vivo Properties of DOTA‐Conjugated Dimeric [Tyr3]Octreotate Peptides Synthesized by a “CuI‐Click” and “Sulfo‐Click” Ligation Method

We report on the SSTR2‐binding properties of a series of four dimeric [Tyr3]octreotate analogues with different spacer lengths (nine, 19, 41, and 57 atoms) between the peptides. Two analogues (9 and 57 atoms) were selected as precursors for the design, synthesis, and biological evaluation of DOTA‐conjugated dimeric [Tyr3]octreotate analogues for tumor targeting. These compounds were synthesized by using a two‐stage click ligation procedure: a CuI‐catalyzed 1,3‐dipolar cycloaddition (“copper‐click” reaction) and a thio acid/sulfonyl azide amidation (“sulfo‐click” reaction). The IC50 values of these DOTA‐conjugated [Tyr3]octreotate analogues were comparable, and internalization studies showed that the nine‐atom 111In‐DOTA‐labeled [Tyr3]octreotate dimer had rapid and high receptor binding. Biodistribution studies with BALB/c nude mice bearing subcutaneous AR42J tumors showed that the 111In‐labeled [Tyr3]octreotate dimer (nine atoms) had a high tumor uptake at 1 h p.i. (38.8±8.3 % ID g−1), and excellent tumor retention at 4 h p.i. (40.9±2.5 % ID g−1). However, the introduction of the extended hydrophilic 57 atoms spacer led to rapid clearance from the circulation; this limited tumor accumulation of the radiotracer (21.4±4.9 % ID g−1 at 1 h p.i.). These findings provide important insight on dimerization and spacer effects on the in vivo properties of DOTA‐conjugated [Tyr3]octreotate dimers.

[1]  E. Novellino,et al.  Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors. , 2010, Journal of medicinal chemistry.

[2]  J. G. García Fernández,et al.  Multimeric Lactoside “Click Clusters” as Tools to Investigate the Effect of Linker Length in Specific Interactions with Peanut Lectin, Galectin‐1, and ‐3 , 2010, Chembiochem : a European journal of chemical biology.

[3]  R. Liskamp,et al.  Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed "click" cycloaddition and thio acid/sulfonyl azide "sulfo-click" amidation and their in vivo evaluation. , 2010, Journal of medicinal chemistry.

[4]  R. Roy,et al.  Design and Creativity in Synthesis of Multivalent Neoglycoconjugates , 2010, Advances in Carbohydrate Chemistry and Biochemistry.

[5]  R. Valkema,et al.  Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. , 2010, Endocrine-related cancer.

[6]  U. Kumar,et al.  The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5 , 2010, Regulatory Peptides.

[7]  Arwin J. Brouwer,et al.  ‘Sulfo‐click’ for ligation as well as for site‐specific conjugation with peptides, fluorophores, and metal chelators , 2010, Journal of peptide science : an official publication of the European Peptide Society.

[8]  Shuang Liu Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. , 2009, Bioconjugate chemistry.

[9]  R. Valkema,et al.  Tumor imaging and therapy using radiolabeled somatostatin analogues. , 2009, Accounts of chemical research.

[10]  Zhili Liu,et al.  Design of multivalent ligand targeting G-protein-coupled receptors. , 2009, Current pharmaceutical design.

[11]  Fan Wang,et al.  68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[13]  J. Meienhofer,et al.  Solid phase synthesis without repetitive acidolysis. Preparation of leucyl-alanyl-glycyl-valine using 9-fluorenylmethyloxycarbonylamino acids. , 2009, International journal of peptide and protein research.

[14]  Young-Seung Kim,et al.  Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers. , 2008, Journal of medicinal chemistry.

[15]  Xiaoyuan Chen,et al.  68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  G. Visser,et al.  Strong inhibition of cholera toxin binding by galactose dendrimers. , 2007, Chemical communications.

[17]  Cristina Sisu,et al.  Strong Inhibition of Cholera Toxin by Multivalent GM1 Derivatives , 2007, Chembiochem : a European journal of chemical biology.

[18]  Arwin J. Brouwer,et al.  Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes. , 2007, Organic & biomolecular chemistry.

[19]  W. Oyen,et al.  Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  Shuang Liu,et al.  Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer. , 2006, Bioconjugate chemistry.

[21]  L. Williams,et al.  Mechanism of thio acid/azide amidation. , 2006, Journal of the American Chemical Society.

[22]  Arwin J. Brouwer,et al.  Efficient microwave-assisted synthesis of multivalent dendrimeric peptides using cycloaddition reaction (click) chemistry. , 2005, Chemical communications.

[23]  Arwin J. Brouwer,et al.  Highly efficient coupling of beta-substituted aminoethane sulfonyl azides with thio acids, toward a new chemical ligation reaction. , 2005, Organic letters.

[24]  U. Kumar,et al.  Agonist-dependent Dissociation of Human Somatostatin Receptor 2 Dimers , 2004, Journal of Biological Chemistry.

[25]  W. Meyerhof,et al.  Regulation and function of somatostatin receptors , 2004, Journal of neurochemistry.

[26]  L. Kvols,et al.  Peptide Receptor Radionuclide Therapy , 2004, Annals of the New York Academy of Sciences.

[27]  R. Autar,et al.  Adhesion Inhibition of F1C‐Fimbriated Escherichia coli and Pseudomonas aeruginosa PAK and PAO by Multivalent Carbohydrate Ligands , 2003, Chembiochem : a European journal of chemical biology.

[28]  Christian Bruns,et al.  Opportunities in somatostatin research: biological, chemical and therapeutic aspects , 2003, Nature Reviews Drug Discovery.

[29]  L. Williams,et al.  The reaction of thio acids with azides: a new mechanism and new synthetic applications. , 2003, Journal of the American Chemical Society.

[30]  R. Liskamp,et al.  Rigidified multivalent lactose molecules and their interactions with mammalian galectins: a route to selective inhibitors. , 2003, Organic & biomolecular chemistry.

[31]  J. Reubi,et al.  A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors. , 2002, European journal of pharmacology.

[32]  W. Oyen,et al.  Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting. , 2002, Cancer biotherapy & radiopharmaceuticals.

[33]  Milind Rajopadhye,et al.  Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. , 2002, Cancer research.

[34]  Crider Am Recent advances in the development of nonpeptide somatostatin receptor ligands. , 2002, Mini reviews in medicinal chemistry.

[35]  Luke G Green,et al.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.

[36]  G. Meno-Tetang,et al.  SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. , 2002, European journal of endocrinology.

[37]  Morten Meldal,et al.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.

[38]  J. Rivier,et al.  Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1). , 2001, Journal of medicinal chemistry.

[39]  Arwin J. Brouwer,et al.  Convergent Synthesis and Diversity of Amino Acid Based Dendrimers , 2001 .

[40]  J. Taylor,et al.  N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity. , 2001, Journal of medicinal chemistry.

[41]  U. Kumar,et al.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.

[42]  U. Kumar,et al.  Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.

[43]  R. Read,et al.  Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.

[44]  G. Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[45]  G. M. Whitesides,et al.  Polyvalente Wechselwirkungen in biologischen Systemen: Auswirkungen auf das Design und die Verwendung multivalenter Liganden und Inhibitoren , 1998 .

[46]  R. Kramer,et al.  Spanning binding sites on allosteric proteins with polymer-linked ligand dimers , 1998, Nature.

[47]  E P Krenning,et al.  Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. , 1998, Cancer research.

[48]  S. Lamberts,et al.  Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. , 1995, Endocrinology.

[49]  H. Niznik,et al.  The somatostatin receptor family. , 1995, Life sciences.

[50]  A. Varki Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[51]  Jing Zhang,et al.  Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications , 1991 .

[52]  D. Coy,et al.  Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin. , 1987, Life sciences.

[53]  J. Epelbaum Somatostatin in the central nervous system: Physiology and pathological modifications , 1986, Progress in Neurobiology.

[54]  S. Reichlin Somatostatin. , 1983, The New England journal of medicine.

[55]  P. Marbach,et al.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.

[56]  Ruth F. Nutt,et al.  A potent cyclic hexapeptide analogue of somatostatin , 1981, Nature.

[57]  E. V. Arx,et al.  Das 4,4′-tetramethyldiamino-diphenylmethan reagens (TDM) , 1976 .

[58]  N. Ling,et al.  Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone , 1973, Science.

[59]  P. Valent,et al.  Tc-p829 99m of a Novel Tumor Tracer, Binding in Vivo Somatostatin Receptor Subtype Specificity and Updated Version Citing Articles E-mail Alerts Somatostatin Receptor Subtype Specificity and in Vivo Binding of a Novel Tumor Tracer, 99mtc-p8291 , 2013 .

[60]  U. Kumar,et al.  Somatostatin and somatostatin receptors. , 2010, Results and problems in cell differentiation.

[61]  Young-Seung Kim,et al.  Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. , 2009, Molecular pharmaceutics.

[62]  Fan Wang,et al.  Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer. , 2008, Bioconjugate chemistry.

[63]  W. Oyen,et al.  Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide. , 2007, Nuclear medicine and biology.

[64]  P. Sieber An improved method for anchoring of 9-fluorenylmethoxycarbonyl-amino acids to 4-alkoxybenzyl alcohol resins. , 1987 .

[65]  S. Reichlin Somatostatin (First of two parts) , 1983 .

[66]  R. Guillemin,et al.  Somatostatin: physiological and clinical significance. , 1976, Annual review of medicine.